Literature DB >> 10469715

Mannan binding lectin concentration and risk of miscarriage.

D C Kilpatrick1, L Starrs, S Moore, V Souter, W A Liston.   

Abstract

Recurrent miscarriage is associated with low concentrations of mannan-binding lectin (MBL), but it is not known below which value relative MBL deficiency becomes a significant risk factor. The sera of 397 patients (male and female) suffering from recurrent miscarriage and 376 controls were assayed for MBL and the data analysed. It was found that the lower the cut-off value, the greater the statistical strength of the association. It was concluded that only MBL concentrations </=0.1 microg/ml were clinically significant in this context. A corollary of this conclusion is that genotyping for point mutations in the structural gene for MBL would be a much less sensitive means of identifying couples at risk of experiencing recurrent miscarriage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469715     DOI: 10.1093/humrep/14.9.2379

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes.

Authors:  N Baxter; M Sumiya; S Cheng; H Erlich; L Regan; A Simons; J A Summerfield
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Mannose binding lectin genotypes are not associated with increased risk of unexplained recurrent pregnancy loss.

Authors:  Dara S Berger; Zaher Merhi; W Allen Hogge; Robert E Ferrell
Journal:  J Assist Reprod Genet       Date:  2013-04-07       Impact factor: 3.412

3.  A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Adi L Tarca; Samuel S Edwin; Jung-Sun Kim; Sonia S Hassan; Jimmy Espinoza; Pooja Mittal; Shali Mazaki-Tovi; Lara Friel; Francesca Gotsch; Edi Vaisbuch; Natalia Camacho; Zoltan Papp
Journal:  Am J Reprod Immunol       Date:  2008-10       Impact factor: 3.886

4.  No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections.

Authors:  D C Kilpatrick; L A McLintock; E K Allan; M Copland; T Fujita; N E Jordanides; C Koch; M Matsushita; H Shiraki; K Stewart; M Tsujimura; M L Turner; I M Franklin; T L Holyoake
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

5.  Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis.

Authors:  Hiroyuki Inoshita; Isao Ohsawa; Gaku Kusaba; Masaya Ishii; Kisara Onda; Satoshi Horikoshi; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2010-12-06       Impact factor: 2.388

Review 6.  Clinical manifestations of mannan-binding lectin deficiency.

Authors:  S Thiel; P D Frederiksen; J C Jensenius
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.